Sec Form 4 Filing - BANK OF AMERICA CORP /DE/ @ NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUND

Insider filing report for Changes in Beneficial Ownership

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Here is the list of insider trading transaction codes

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

November 30, 2011

Estimated average burden hours per response...

0.5

1. Name and Address of Reporting Person

BANK OF AMERICA CORP /DE/

2. Issuer Name and Ticker or Trading Symbol
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUND [ NAN]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	X __ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

BANK OF AMERICA CORPORATE CENTER, 100 N. TRYON STREET

3. Date of Earliest Transaction (MM/DD/YY)
05/07/2015

(Street)

CHARLOTTE, NC28255

4. If Amendment, Date Original Filed (MM/DD/YY)

6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

**Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned**
1.Title of Security (Instr. 3)	2. Transaction Date (MM/DD/YY)	2A. Deemed Execution Date, if any (MM/DD/YY)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (MM/DD/YY)	2A. Deemed Execution Date, if any (MM/DD/YY)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	05/07/2015		P		1,000	A	$ 13.7299	1,000	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	05/07/2015		S		1,000	D	$ 13.6854	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	10/07/2015		S		200	D	$ 13.6276	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	10/07/2015		S		33	D	$ 13.6276	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	10/07/2015		S		17	D	$ 13.6276	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	10/08/2015		P		250	A	$ 13.6299	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	11/02/2015		P		103	A	$ 13.8267	103	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	11/02/2015		P		59	A	$ 13.8267	162	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	11/11/2015		S		162	D	$ 13.5568	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	12/18/2015		S		12	D	$ 13.95	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	12/21/2015		P		12	A	$ 14.0475	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	02/26/2016		P		1,925	A	$ 14.4099	1,925	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	02/26/2016		S		1,400	D	$ 14.3952	525	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	02/26/2016		S		525	D	$ 14.39	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	03/02/2016		S		247	D	$ 14.28	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	03/02/2016		P		247	A	$ 14.2799	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	03/16/2016		P		25	A	$ 14.498	25	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	03/17/2016		S		25	D	$ 14.4801	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	04/22/2016		S		40	D	$ 15.1125	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	04/26/2016		P		40	A	$ 15.1099	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	06/27/2016		P		43	A	$ 15.4575	43	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	07/01/2016		S		43	D	$ 15.6725	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	07/18/2016		P		64	A	$ 15.6464	64	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	07/18/2016		S		64	D	$ 15.621	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	06/22/2017		S		279	D	$ 14.0647	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	06/22/2017		P		100	A	$ 14.08	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	06/22/2017		P		79	A	$ 14.08	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	06/22/2017		P		100	A	$ 14.08	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	11/01/2017		P		2,515	A	$ 13.86	2,515	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Common Stock ^{( 1 )} ^{( 2 )} ^{( 3 )}	11/02/2017		S		2,515	D	$ 13.8225	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}

**Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned**
( *e.g.* , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (MM/DD/YY)	3A. Deemed Execution Date, if any (MM/DD/YY)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (MM/DD/YY)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (MM/DD/YY)	3A. Deemed Execution Date, if any (MM/DD/YY)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 4 )}	09/08/2022		S/K			285	^{( 4 )}	10/31/2023	Common Stock	285	^{( 4 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 5 )}	09/13/2022		P/K		285		^{( 5 )}	10/31/2023	Common Stock	285	^{( 5 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 5 )}	09/13/2022		S/K			115	^{( 5 )}	10/31/2023	Common Stock	115	^{( 5 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 6 )}	09/14/2022		P/K		115		^{( 6 )}	10/31/2023	Common Stock	115	^{( 6 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 7 )}	09/14/2022		P/K		26		^{( 7 )}	10/31/2023	Common Stock	26	^{( 7 )}	26	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 8 )}	10/04/2022		S/K			26	^{( 8 )}	10/31/2023	Common Stock	26	^{( 8 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 9 )}	10/04/2022		S/K			932	^{( 9 )}	10/31/2023	Common Stock	932	^{( 9 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 10 )}	10/05/2022		P/K		932		^{( 10 )}	10/31/2023	Common Stock	932	^{( 10 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 10 )}	10/05/2022		S/K			1,925	^{( 10 )}	10/31/2023	Common Stock	1,925	^{( 10 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 11 )}	10/11/2022		P/K		1,925		^{( 11 )}	10/31/2023	Common Stock	1,925	^{( 11 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 11 )}	10/11/2022		S/K			1,298	^{( 11 )}	10/31/2023	Common Stock	1,298	^{( 11 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 12 )}	10/12/2022		P/K		1,298		^{( 12 )}	10/31/2023	Common Stock	1,298	^{( 12 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 12 )}	10/12/2022		S/K			1,189	^{( 12 )}	10/31/2023	Common Stock	1,189	^{( 12 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 13 )}	10/20/2022		P/K		1,189		^{( 13 )}	10/31/2023	Common Stock	1,189	^{( 13 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 13 )}	10/20/2022		S/K			1,737	^{( 13 )}	10/31/2023	Common Stock	1,737	^{( 13 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 14 )}	10/27/2022		P/K		1,737		^{( 14 )}	10/31/2023	Common Stock	1,737	^{( 14 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 14 )}	10/27/2022		S/K			2,081	^{( 14 )}	10/31/2023	Common Stock	2,081	^{( 14 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 15 )}	11/01/2022		P/K		2,081		^{( 15 )}	10/31/2023	Common Stock	2,081	^{( 15 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 15 )}	11/01/2022		S/K			2,037	^{( 15 )}	10/31/2023	Common Stock	2,037	^{( 15 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 16 )}	11/02/2022		P/K		2,037		^{( 16 )}	10/31/2023	Common Stock	2,037	^{( 16 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 16 )}	11/02/2022		S/K			1,176	^{( 16 )}	10/31/2023	Common Stock	1,176	^{( 16 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 17 )}	11/02/2022		P/K		1,176		^{( 17 )}	10/31/2023	Common Stock	1,176	^{( 17 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 17 )}	11/02/2022		S/K			1,024	^{( 17 )}	10/31/2023	Common Stock	1,024	^{( 17 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 18 )}	11/03/2022		P/K		1,024		^{( 18 )}	10/31/2023	Common Stock	1,024	^{( 18 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 18 )}	11/03/2022		S/K			493	^{( 18 )}	10/31/2023	Common Stock	493	^{( 18 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 19 )}	11/03/2022		P/K		493		^{( 19 )}	10/31/2023	Common Stock	493	^{( 19 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 19 )}	11/03/2022		S/K			361	^{( 19 )}	10/31/2023	Common Stock	361	^{( 19 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 20 )}	11/04/2022		P/K		361		^{( 20 )}	10/31/2023	Common Stock	361	^{( 20 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 20 )}	11/04/2022		S/K			264	^{( 20 )}	10/31/2023	Common Stock	264	^{( 20 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}
Equity Swap ^{( 1 )} ^{( 2 )} ^{( 3 )}	^{( 21 )}	11/04/2022		P/K		264		^{( 21 )}	10/31/2023	Common Stock	264	^{( 21 )}	0	I	See Footnotes ^{( 1 )} ^{( 2 )} ^{( 3 )}

**Reporting Owners**
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORPORATE CENTER 100 N. TRYON STREET CHARLOTTE, NC28255		X
MERRILL LYNCH, PIERCE, FENNER & SMITH INC. ONE BRYANT PARK NEW YORK, NY10036		X
BOFA SECURITIES, INC. ONE BRYANT PARK NEW YORK, NY10036		X
BANK OF AMERICA NA 100 NORTH TRYON STREET CHARLOTTE, NC28255		X

**Signatures**
BANK OF AMERICA CORP /DE/ By: Bank of America Corp /DE/ Its: Authorized Signatory Andres Ortiz		12/13/2024
Signature of Reporting Person		Date
Merrill Lynch, Pierce, Fenner & Smith Incorporated By: Merrill Lynch, Pierce, Fenner & Smith Incorporated Its: Authorized Signatory Andres Ortiz		12/13/2024
Signature of Reporting Person		Date
BofA Securities, Inc. By: BofA Securities, Inc. Its: Authorized Signatory Andres Ortiz		12/13/2024
Signature of Reporting Person		Date
Bank of America, N.A. By: Bank of America, N.A. Its: Authorized Signatory Andres Ortiz		12/13/2024
Signature of Reporting Person		Date

Explanation of Responses:

( 1 )This statement is jointly filed by Bank of America Corporation, Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), BofA Securities, Inc. ("BofA Securities"), and Bank of America, N.A. ("BANA") (together, the "Reporting Persons"). Bank of America Corporation holds an indirect interest in the securities listed in this Report by virtue of its 100% ownership of its subsidiaries Merrill Lynch, BofA Securities, and BANA. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Securities Exchange Act of 1934 (the "Exchange Act"), or for any other purpose.
( 2 )Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the Exchange Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
( 3 )Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer.
( 4 )The Reporting Persons entered an equity swap agreement under which, upon the termination of the agreement on October 31, 2023, the counterparty will pay to the Reporting Persons any decrease in the price of the Common Stock below $11.1034 per share and the Reporting Persons will pay to the counterparty any increase in the price of the Common Stock above $11.1034 per share, in each case, based on a notional amount of 285 shares of Common Stock.
( 5 )On September 13, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 115 and to change the reference price used to determine when payments are made to $11.167. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement re flecting the amended terms.
( 6 )On September 14, 2022, the Reporting Persons terminated the equity swap agreement.
( 7 )The Reporting Persons entered an equity swap agreement under which, upon the termination of the agreement on October 31, 2023, the Reporting Persons will pay to the counterparty any decrease in the price of the Common Stock below $11.1714 per share and the counterparty will pay to the Reporting Persons any increase in the price of the Common Stock above $11.1714 per share, in each case, based on a notional amount of 26 shares of Common Stock.
( 8 )On October 4, 2022, the Reporting Persons terminated the equity swap agreement.
( 9 )The Reporting Persons entered an equity swap agreement under which, upon the termination of the agreement on October 31, 2023, the counterparty will pay to the Reporting Persons any decrease in the price of the Common Stock below $10.4049 per share and the Reporting Persons will pay to the counterparty any increase in the price of the Common Stock above $10.4049 per share, in each case, based on a notional amount of 932 shares of Common Stock.
( 10 )On October 5, 2022, the Reporting Persons amended the equity swap agreement to increase the notional number of shares of Common Stock to 1,925 and to change the reference price used to determine when payments are made to $10.2972. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 11 )On October 11, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 1,298 and to change the reference price used to determine when payments are made to $10.2508. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 12 )On October 12, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 1,189 and to change the reference price used to determine when payments are made to $10.2421. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 13 )On October 20, 2022, the Reporting Persons amended the equity swap agreement to increase the notional number of shares of Common Stock to 1,737 and to change the reference price used to determine when payments are made to $9.9915. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 14 )On October 27, 2022, the Reporting Persons amended the equity swap agreement to increase the notional number of shares of Common Stock to 2,081 and to change the reference price used to determine when payments are made to $9.7221. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 15 )On November 1, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 2,037 and to change the reference price used to determine when payments are made to $10.0379. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 16 )On November 2, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 1,176 and to change the reference price used to determine when payments are made to $9.9323. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 17 )On November 2, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 1,024. Without admitting this change resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 18 )On November 3, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 493 and to change the reference price used to determine when payments are made to $9.8658. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 19 )On November 3, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 361. Without admitting this change resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 20 )On November 4, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 264 and to change the reference price used to determine when payments are made to $9.9135. Without admitting these changes resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.
( 21 )On November 4, 2022, the Reporting Persons amended the equity swap agreement to reduce the notional number of shares of Common Stock to 247. Without admitting this change resulted in a material amendment to the equity swap agreement for purposes of Section 16 of the Securities Exchange Act of 1934, the Reporting Persons have treated the amendment as the termination of the previously reported equity swap agreement and the entering into of a new equity swap agreement reflecting the amended terms.

Remarks:
Balance of trades included in attached schedule. (See Exhibit 99.1)Exhibits Index Exhibit 99.2 - Joint Filing Agreement

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Sec Form 4 Filing - BANK OF AMERICA CORP /DE/ @ NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUND - 2015-05-07